Amicus Therapeutics (FOLD) Operating Income (2016 - 2025)
Historic Operating Income for Amicus Therapeutics (FOLD) over the last 17 years, with Q3 2025 value amounting to $34.3 million.
- Amicus Therapeutics' Operating Income rose 5822.06% to $34.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.8 million, marking a year-over-year increase of 52946.48%. This contributed to the annual value of $24.9 million for FY2024, which is 13221.82% up from last year.
- Latest data reveals that Amicus Therapeutics reported Operating Income of $34.3 million as of Q3 2025, which was up 5822.06% from -$9.5 million recorded in Q2 2025.
- In the past 5 years, Amicus Therapeutics' Operating Income registered a high of $34.3 million during Q3 2025, and its lowest value of -$75.3 million during Q1 2022.
- Its 5-year average for Operating Income is -$23.9 million, with a median of -$27.7 million in 2024.
- Per our database at Business Quant, Amicus Therapeutics' Operating Income surged by 53258.4% in 2024 and then tumbled by 16329.93% in 2025.
- Amicus Therapeutics' Operating Income (Quarter) stood at -$72.1 million in 2021, then soared by 41.33% to -$42.3 million in 2022, then surged by 91.28% to -$3.7 million in 2023, then soared by 532.58% to $16.0 million in 2024, then skyrocketed by 114.57% to $34.3 million in 2025.
- Its Operating Income was $34.3 million in Q3 2025, compared to -$9.5 million in Q2 2025 and -$8.0 million in Q1 2025.